Last update 08 May 2025

Indapamide/Valsartan/Levamlodipine Maleate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
AGSAVI
Target
AT1R x L-type calcium channel
Action
antagonists, blockers, inhibitors
Mechanism
AT1R antagonists(Angiotensin II Receptor Type 1 antagonists), L-type calcium channel blockers(Voltage-gated L-type calcium channel blockers), Symporters inhibitors
Therapeutic Areas
Cardiovascular Diseases
Active Indication-
Inactive Indication
Essential Hypertension
Originator Organization
AHN-GOOK PHARMACEUTICAL Co., Ltd.
Active Organization-
Inactive Organization
AHN-GOOK PHARMACEUTICAL Co., Ltd.
License Organization-
Drug Highest PhasePendingPhase 3
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC16H16ClN3O3S
InChIKeyNDDAHWYSQHTHNT-UHFFFAOYSA-N
CAS Registry26807-65-8
View All Structures (3)

Related

2
Clinical Trials associated with Indapamide/Valsartan/Levamlodipine Maleate
NCT05503953
/ Unknown statusPhase 3
A Multicenter, Randomized, Double-blind, Phase III Study to Evaluate the Efficacy and Safety of AGSAVI in Patients With Essential Hypertension Inadequately Controlled With AGLS
NCT04686643
/ Unknown statusPhase 3
A Multicenter, Randomized, Double-blind, Phase III Study to Evaluate the Efficacy and Safety of AGSAVI in Patients With Essential Hypertension Inadequately Controlled With AGLS
100 Clinical Results associated with Indapamide/Valsartan/Levamlodipine Maleate
Login to view more data
100 Translational Medicine associated with Indapamide/Valsartan/Levamlodipine Maleate
Login to view more data
100 Patents (Medical) associated with Indapamide/Valsartan/Levamlodipine Maleate
Login to view more data
100 Deals associated with Indapamide/Valsartan/Levamlodipine Maleate
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Essential HypertensionPhase 3-
AHN-GOOK PHARMACEUTICAL Co., Ltd.
01 Feb 2021
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free